Literature DB >> 22089725

The cardiovascular biomarker conundrum: challenges and solutions.

Vinay Prasad1, Robert O Bonow.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22089725     DOI: 10.1001/jama.2011.1673

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The reversal of cardiology practices: interventions that were tried in vain.

Authors:  Vinay Prasad; Adam Cifu
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

Review 2.  Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure.

Authors:  Stephen J Greene; Robert J Mentz; Mona Fiuzat; Javed Butler; Scott D Solomon; Andrew P Ambrosy; Cyrus Mehta; John R Teerlink; Faiez Zannad; Christopher M O'Connor
Journal:  Circulation       Date:  2018-09-04       Impact factor: 29.690

3.  Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study.

Authors:  George P Bayliss; Larry A Weinrauch; Ray E Gleason; Annette T Lee; John A D'Elia
Journal:  Clin Kidney J       Date:  2013-09-23

4.  Galectin-3 in heart failure: more answers or more questions?

Authors:  Tariq Ahmad; G Michael Felker
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

Review 5.  Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL.

Authors:  Peiqiu Cao; Haitao Pan; Tiancun Xiao; Ting Zhou; Jiao Guo; Zhengquan Su
Journal:  Int J Mol Sci       Date:  2015-07-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.